Bionano Genomics, Inc. (BNGO) News
Follow Bionano Genomics, Inc. (BNGO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Bionano Genomics Q3'26 Earnings Preview: Revenue Estimated at $8.44 Million
Bionano Genomics is scheduled to report Q3'26 results November 10 after the market closes. Revenue is estimated at $8.44 million and EPS at $(0.45).
EQUITY | Nov 09, 2026, 12:02 PM UTC
M
Bionano Genomics Q3'26 Earnings Preview Lists EPS Estimate
Bionano Genomics is expected to report Q3'26 results on October 29; the release time is not specified.
EQUITY | Oct 28, 2026, 11:05 AM UTC
H
Bionano Genomics Stock Surges Tuesday: What's Going On?
Shares of Bionano Genomics Inc. (NASDAQ: BNGO ) are trading sharply higher Tuesday afternoon, expanding multi-session upside as investors digest management’s multi-year growth strategy delivered at a major healthcare con
LIVE | Sep 15, 2026, 07:12 PM UTC
M
Bionano reports Q2 revenue, raises guidance
Bionano Genomics said Q2 2026 revenue was $8.2 million, raised FY26 guidance and gave a FY27 revenue target. It also projected EBITDA break-even in Q4 FY27.
EQUITY | Sep 14, 2026, 12:33 PM UTC
L
Bionano to participate in H.C. Wainwright conference
Bionano said it will participate in the H.C. Wainwright 28th Annual Global Investment Conference.
REGULATION | Aug 24, 2026, 12:00 PM UTC
L
Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est
Bionano Genomics (NASDAQ: BNGO ) raises FY2026 sales outlook from $30.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.137 million estimate.
EARNINGS | Aug 10, 2026, 08:07 PM UTC